News Results for Astrazeneca (AZN)
-
01 Dec
11:45Factory data helps fire FTSE 100 to big gainsPositive factory data from China and the UK put the FTSE 100 in a happy place on 1 December, approaching midday the index was up more than 2% to close on the 6,400 mark. Sterling remained volatile...
-
01 Dec
08:35FTSE opens 1.1% higher on positive China factory dataUK stocks opened more than 1% higher on Tuesday, paring Monday's losses, as positive Chinese factory data fueled global recovery hopes already supported by upbeat Covid-19 vaccine developments. At...
-
01 Dec
07:25AstraZeneca sells Crestor rights to Grunenthal in Europe for up to $350mPharmaceutical giant AstraZeneca agreed to sell the rights to Crestor and associated medicines in over 30 countries in Europe, except the UK and Spain, to Grunenthal for up to $350 million. The...
-
30 Nov
16:36FTSE down sharply by the close as US stocks slumpHaving started the day in the black the FTSE 100 closed down more than 1% and falling below the 6,300 mark. In doing so it took its cue from the US where the S&P 500 was down 0.9% to 3,604.30...
-
30 Nov
12:12FTSE flat as sterling gains on Brexit hopesThe FTSE 100 surrendered earlier gains to trade flat at midday at 6,365.18. Contributing to the intra-day decline in the fortunes of the index were raised hopes of a Brexit deal. These helped push...
-
30 Nov
08:43FTSE ekes out modest gains in early tradeUK stocks made modest gains on Monday morning as investors weighed optimism about a potential Covid-19 vaccine against fears of a more severe economic fallout from the pandemic as cases continue to...
-
30 Nov
07:15AstraZeneca's diabetes drug wins approval for heart failure treatment in JapanPharmaceutical giant AstraZeneca said its diabetes drug Forxiga had been approved in Japan to treat patients with chronic heart failure. The approval was based on positive results from the DAPA-HF...
-
27 Nov
12:30Little to lift FTSE at lunchtime as UK frets over new tier restrictionsThe UK's leading shares continued to drift lower at lunchtime on Friday as investors mull new sweeping stiff restrictions that will see limited opportunities for thousands of businesses across...
-
23 Nov
17:29FTSE finishes slightly lower as vaccine news disappointsLondon's FTSE 100 struggled to make headway on Monday, creeping into the red by the close on news the coronavirus vaccine developed by Oxford University, and to be manufactured by pharmaceutical...
-
23 Nov
12:19FTSE firms on vaccine news, investors toast pub stocksUK stocks began the week strongly on news the coronavirus vaccine developed by Oxford University, and to be manufactured by pharmaceutical giant AstraZeneca, has been shown to be 70% effective in...
-
23 Nov
08:34UK stocks open 0.4% higher on positive vaccine newsUK stocks opened higher on Monday after pharmaceutical company AstraZeneca released positive trial results for a Covid-19 vaccine, adding to recent encouraging results from rivals Pfizer and...
-
23 Nov
07:44AstraZeneca says its Covid-19 vaccine 70% effectivePharmaceutical company AstraZeneca said clinical trials in the UK and Brazil showed its Covid-19 vaccine, being developed with Oxford University, had an average efficacy of 70% in protecting...
-
20 Nov
16:49FTSE 100 holds on to mark a positive end to the weekAmid several competing catalysts around Brexit, Covid and vaccines the FTSE 100 closed out the week up 0.3% at 6,351.45. In the US the S&P 500 retreated 0.16% to 3,575,98 by 4.30pm UK time....
-
20 Nov
12:01FTSE 100 builds on early gains amid latest Brexit developmentsSterling nudged slightly ahead amid briefings suggesting a Brexit deal is gradually moving closer. By midday the FTSE 100 was up 0.5% to 6,366.15, with US futures markets suggesting a mixed open on...
-
20 Nov
08:56FTSE flat as more positive vaccine news emergesThe FTSE 100 index was broadly flat in early trading this morning as more positive news emerged about potential Covid-19 vaccines. Shares in software company Sage Group dropped 10.9% to 606p after...
-
20 Nov
07:17AstraZeneca's non-small cell lung cancer drug wins approval in US for additional dosing optionPharmaceutical giant AstraZeneca said its antibody imfinzi had been approved in the US for an additional dosing option to treat non-small cell lung cancer after chemoradiation therapy and...
-
19 Nov
16:37Covid and Brexit uncertainty hit sentiment with FTSE closing lowerNews that a member of the EU's Brexit negotiating team is isolating after testing positive for coronavirus, with talks put on on hold, as well as continuing fears over the economic impact of the...
-
19 Nov
12:05FTSE takes its cue from US weakness to trade lowerTightened restrictions in the US amid a worsening Covid situation helped push the FTSE 100 lower, by midday the index was down 0.8% to 6,334.75 with US futures pointing to future weakness on Wall...
-
19 Nov
09:16UK stocks lower as fears over extended lockdown offset positive vaccine newsUK stocks turned negative after opening higher Thursday as fears about a longer lockdown overshadowed positive vaccine news amid worries that Covid-19 restrictions will slow the economic recovery....
-
10 Nov
17:00FTSE closes significantly higher as vaccine rally continuesThe FTSE 100 closed 1.79% higher to 6,296.85 on Tuesday as the positive sentiment imbued by encouraging news on a Covid-19 vaccine continues to hold. Stocks beaten down in the wake of the pandemic...
-
10 Nov
09:02FTSE 100 builds on vaccine inspired gainsThe FTSE 100 was up 0.9% to 6,241.95 in early trading building on the substantial gains chalked up yesterday thanks to positive news on a Covid-19 vaccine being developed by Pfizer. Real estate...
-
10 Nov
07:26AstraZeneca announces positive results from asthma drug trialAstraZeneca and Amgen announced positive results from the NAVIGATOR Phase III trial for the potential new medicine tezepelumab in patients with severe, uncontrolled asthma. NAVIGATOR met the...
-
09 Nov
12:05Reports of Pfizer vaccine send markets soaringThe FTSE 100 exploded into life just before lunch on Monday on news that a vaccine being developed by Pfizer is 90% effective against Covid. The FTSE 100 was up 3.4% to 6,112.64 on hopes that the...
-
09 Nov
08:55FTSE 100 rises as Biden's US election win brings certainty to marketsThe FTSE 100 rose after markets opened this morning as enthusiasm stayed strong in the aftermath of Joe Biden's US election victory. British house builder Taylor Wimpey has said it expects to end...
-
09 Nov
07:37Astra's chronic lymphocytic leukaemia treatment gets EU clearanceAstraZeneca's said its drug Calquence had received European Union approval for the treatment of adult patients with chronic lymphocytic leukaemia (CCL) adding to approvals already received in the...
-
06 Nov
16:36Markets muted as Biden closes on presidencyWith Biden leading in the key swing state of Philadelphia and a better-than-expected US jobs report out the muted reaction in the markets suggested the likely outcome of the election had already...
-
06 Nov
12:15FTSE dips back below 5,900 with US election and jobs report in focusFTSE dips back below 5,900 with US election and jobs report in focus The FTSE 100 lost some ground by midday, down 0.1% to 5,897.03, after a strong run this week around the US election. Incumbent...
-
06 Nov
08:29AstraZeneca's Brilinta wins approval in USDrugmaker AstraZeneca said its Brilinta drug was approved in the US to reduce the risk of stroke or death in patients with acute ischemic stroke or high-risk transient ischaemic attack. The...
-
05 Nov
16:38Presidential votes still being counted as FTSE makes solid gains and S&P 500 2% higherThe FTSE 100 closed above 5,900 for the first time since mid-October as investors continued to await the result of a tight and contentious presidential election which appears to be heading the way...
-
05 Nov
12:07FTSE 100 momentum builds to trade above 5,900 with stimulus, election in focusBy midday the FTSE 100 was solidly higher, up 0.4% at 5,906.14, after the Bank of England a new £150 billion stimulus package and most observers (and the bookmakers) pointed to Joe Biden as the...
-
05 Nov
09:35FTSE 100 rises as Biden looks set to win US electionThe FTSE 100 index rose in the early hours of trading this morning despite Brexit jitters as Joe Biden’s election victory came into view, while the Bank of England boosted its quantitative easing...
-
05 Nov
07:43AstraZeneca maintains guidance after profit jumps in Q3 on strength in cancer drugsPharma giant AstraZeneca maintained its guidance after reporting a jump in third-quarter profit as revenue was boosted by strength in its portfolio of cancer drugs. For the three months ended...
-
04 Nov
17:36FTSE ends election day higher, AstraZeneca advances on vaccine hopesUK equities ended Wednesday's session in positive territory despite the result of the US election hanging in the balance, with postal ballots still being counted. A change at the White House is...
-
04 Nov
11:58Markets (and Biden) gain ground after earlier sell-offWith the result of the US election still in doubt as postal ballots continue to be counted the FTSE 100 shrugged off the uncertainty. It joined other European markets in moving higher amid signs...
-
04 Nov
08:46Markets volatile after Trump victory claimIncumbent Donald Trump's decision to claim victory and call for the counting of votes to be stopped in a very tight presidential election led to nervousness in the markets on Wednesday morning....
-
30 Oct
07:20AstraZeneca sell Atacand rights to Cheplapharm for $400mPharma giant AstraZeneca said it had agreed to sell the rights to Atacand and Atacand Plus, both used to treat heart failure and hypertension, in around 70 countries to Cheplapharm for $400...
-
28 Oct
07:20AstraZeneca positive clinical data for Forxiga approved in China; gastric cancer drug gets priority review in USPharma giant AstraZeneca said Chinese health authorities had updated the label for Forxiga to include data from a clinical trial showing the drug 'significantly' reduced heart failure or death in...
-
20 Oct
16:36FTSE 100 closes higher with US stocks clawing back yesterday's lossesThe FTSE 100 closed 0.26% higher at 5,900.07, taking its cue from a strong start to trading on Wall Street amid continuing hopes that a stimulus package can be agreed between Democrats and...
-
20 Oct
12:03FTSE 100 back in the black by lunchtime amid continuing sterling volatilityWeakness in the pound amid warnings on the health of the UK economy from the Bank of England and concerns over a no deal Brexit helped erase the FTSE 100's losses by lunchtime on Tuesday. A fall...
-
20 Oct
07:17AstraZeneca's lung cancer drug candidate gets priority review in USPharmaceutical giant AstraZeneca said its non-small-cell lung cancer drug candidate had been been given a regulatory nod for priority review in the US. Tragrisso had received acceptance for a...
-
19 Oct
16:37FTSE 100 closes lower as pound gains on revived Brexit hopesThe FTSE 100 closed firmly lower, down 0.6% at 5,884.65, not helped by strength in sterling amid signs negotiations between the EU and UK are set to intensify despite tough rhetoric on both sides....
-
19 Oct
12:00FTSE 100 on the wane by lunchtime as China, vaccine boost fadesThe FTSE 100 lost ground by lunchtime to trade 0.2% lower at 5,910.59 as an initial kicker from US stimulus hopes, vaccine developments and Chinese economic data waned. European markets also...
-
19 Oct
08:41UK stocks open 0.6% higher on US stimulus hopesUK stocks opened higher on Monday amid hopes that US lawmakers can agree on a fresh round of stimulus, as the Covid-19 caseload continues to surge around the globe. At 0826, the benchmark FTSE 100...
-
19 Oct
07:17AstraZeneca's receives positive opinion on heart failure, lung disease drugs in EUPharmaceutical giant AstraZeneca said its diabetes drug had been recommended for marketing authorisation in the European Union to treat chronic heart failure with reduced ejection fraction in...
-
12 Oct
11:53FTSE flat as investors await new Covid restrictionsUK stocks traded sideways at lunchtime on Monday as investors readied themselves for the introduction of new local Covid-19 measures to be outlined later in the day by prime minister Boris...
-
12 Oct
08:41FTSE opens 0.2% weaker as investors brace for new Covid-19 restrictionsUK stocks opened lower on Monday as investors braced for the introduction of new local Covid-19 restrictions, expected to be outlined later in the day by Prime Minister Boris Johnson. At 0826, the...
-
12 Oct
07:41AstraZeneca to begin third phase trials of Covid-19 antibody treatmentPharmaceutical company AstraZeneca said its coronavirus antibody treatment would advance to two separate phase-three clinical trials at sites in and outside the US that would begin in the coming...
-
02 Oct
12:04FTSE heads lower at midday Friday on increased risk aversionUK stocks traded lower at midday on Friday following weaker European markets as risk aversion was the order of the day amid rising volatility after news that Donald Trump tested positive for...
-
02 Oct
08:40FTSE opens 0.6% lower after Trump tests positive for Covid-19UK stocks opened lower on Friday after Donald Trump tested positive for Covid-19, adding an extra element of political uncertainty in the US just a month before the presidential election. At 0828,...
-
02 Oct
07:24AztraZeneca's diabetes drug gets breakthrough therapy designation in USPharmaceutical company AstraZeneca said its diabetes drug had been granted breakthrough therapy designation in the US to treat patients with chronic kidney disease with and without type-2...
-
21 Sep
07:19AstraZeneca, Merck prostate cancer drug gets regulatory nod in EUPharmaceutical company AstraZeneca and Merck said their drug to treat prostate cancer had received marketing authorisation in the European Union. The approval was based on a subgroup analysis of...
-
14 Sep
16:41UK Stocks end Monday slightly lowerUK stocks closed slightly lower on Monday, despite positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 16:30, the benchmark FTSE 100 index was down 0.1%, at 6,032....
-
14 Sep
12:05UK stocks drift lower Monday lunchtime, G4S receives all cash offerUK stocks drifted lower during the morning session on Monday, despite positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 12:00, the benchmark FTSE 100 index was down...
-
14 Sep
08:51AstraZeneca resumes UK coronavirus vaccine trialPharma giant AstraZeneca said it had resumed British clinical trials of its Covid-19 vaccine following a brief pause that was caused by a participant experiencing an adverse reaction. Clinical...
-
14 Sep
08:42UK stocks open 0.6% higher on positive vaccine newsUK stocks opened higher on Monday, buoyed by positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 0830, the benchmark FTSE 100 index was up 34.72 points, or 0.6%, at...
-
10 Sep
17:04FTSE recovers some losses as pound weakens on EU warningThe FTSE 100 recovered some of its losses in afternoon trading on Thursday to move back above the 6,000 mark, as a weaker pound helped the index. The currency fell significant against the euro and...
-
10 Sep
12:06FTSE falls sharply as mass testing set to cost £100bnThe FTSE 100 fell sharply by lunchtime trading on Thursday as it was revealed the Government's mass coronavirus testing plan will cost £100bn, according to a leaked memo seen by the British Medical...
-
10 Sep
09:16'Moonshot' mass testing fails to lift FTSE; Dixons Carphone electrifiesThe UK's flagship index is off to a shaky start as it was revealed that Prime Minister Boris Johnson's plans to implement mass COVID-19 testing, which would see millions of people tested daily and...
-
10 Sep
07:35AstraZeneca study of chronic rhinosinusitis drug meets primary endpointsPharma giant AstraZeneca said the phase 3 trial for its drug to treat patients with chronic rhinosinusitis with nasal polyps had met its primary objectives. Results from study showed...
-
09 Sep
08:00AstraZeneca reportedly pauses Covid-19 trial after participant suffers illnessAstraZeneca and Oxford University reportedly paused their Covid-19 vaccine study after a UK participant in the trial suffered a suspected serious adverse reaction, according to Stat News....
-
01 Sep
17:06FTSE falls as stronger pound weighs; Saga sails higher on funding dealUK stocks finished in negative territory on Tuesday, despite an advance for stocks on Wall Street, as a stronger pound weighed on exporters, offsetting some encouraging Chinese and UK manufacturing...
-
01 Sep
11:49FTSE lower at lunchtime; Saga soars on funding dealUK stocks edged lower on Tuesday after a stronger pound weighed on exporters, offsetting some positive manufacturing data from China. Financial stocks also weighed on the FTSE 100 with investors...
-
01 Sep
08:40UK stocks drift lower; Saga soars on funding dealUK stocks edged lower in early trade on Tuesday after a stronger pound weighed on exporters, offsetting some positive manufacturing data from China. At 0827, the benchmark FTSE 100 index was down...
-
01 Sep
07:21AstraZeneca reports positive kidney disease trial results; lung cancer drug approvedPharmaceutical company AstraZeneca reported positive clinical results for its drug to treat patients with chronic kidney disease with and without type-2 diabetes. Results from the phase III...
-
01 Sep
07:15Oxford Biomedica, AstraZeneca ink Covid-19 vaccine supply dealGene and cell therapy group Oxford Biomedica said it had signed an 18-month supply agreement with AstraZeneca for commercial manufacture of a Covid-19 vaccine candidate. The deal was part of a...
-
25 Aug
16:55FTSE plunges as US consumer confidence dropsAfter rallying over 1% this morning, the FTSE 100 swung the other way on Tuesday afternoon to close deeply in the red, as a surging pound and plummeting US consumer confidence dragged the index...
-
25 Aug
08:27FTSE opens 1% higher on US-China trade progress; acquisition activityUK stocks opened 1% higher on Tuesday after the US and China said they'd made progress in trade talks and software group Aveva announced a bumper $5bn (£3.8bn) takeover deal. At 0819, the...
-
25 Aug
07:14AstraZeneca doses first patients in Covid-19 clinical trialPharma giant AstraZeneca said the first participants had been dosed in a phase I trial of its potential Covid-19 treatment. The trial, called NCT04507256, would evaluate the safety,...
-
24 Aug
18:56Firm US open fuels FTSE gains at close on virus vaccine hopes and buyout talkUK markets closed on Monday firmly in positive territory buoyed by new hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months, while takeover...
-
24 Aug
12:39FTSE surges 1.85% higher on virus vaccine hopes and buyout talkUK markets rallied strongly through the morning session on Monday, buoyed by new hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months, and takeover...
-
24 Aug
08:48AstraZeneca rises as Trump reportedly looking to fast-track UK Covid-19 vaccineAstraZeneca rose on Monday after the Financial Times reported that the Trump administration was considering fast-tracking approval of its Covid-19 vaccine ahead of the US presidential election in...
-
24 Aug
08:41FTSE opens 1.5% higher on Covid-19 vaccine hopesUK stocks opened substantially higher on Monday amid hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months. At 0824, the benchmark FTSE 100 index...
-
21 Aug
17:11FTSE finishes in the red amid climbing Covid cases, Barnier's Brexit warningLondon's FTSE 100 ended Friday's session in the red as a resurgence of Covid-19 cases in Europe, a growing number of outbreaks in the UK and a warning from Michel Barnier that a UK-EU Brexit trade...
-
21 Aug
12:01FTSE creeps into positive territory despite climbing Covid-19 casesBritain's main stock index edged higher on Friday, despite skittishness caused by a resurgence of Covid-19 cases in Europe. At 11.36, the benchmark FTSE 100 index was marginally higher, up 0.02%...
-
21 Aug
08:48Renalytix AI to collaborate with AstraZeneca on medicine strategiesKidney disease diagnostics group Renalytix AI said it would collaborate with AstraZeneca to develop medicine strategies for cardiovascular, renal and metabolic diseases. The first stage in the...
-
21 Aug
08:28FTSE drifts below 6,000 points as Covid-19 cases climb in EuropeBritain's main stock index fell below the 6,000-point mark in early trading on Friday, despite the release of positive retail sales figures, as investors remained wary of a resurgence of Covid-19...
-
21 Aug
07:10AstraZeneca lung cancer treatment gets regulatory nod in JapanPharmaceutical giant AstraZeneca said its drug to treat patients with extensive-stage small cell lung cancer had been approved in Japan. Imfinzi (durvalumab) had been approved in combination with...
-
18 Aug
07:16AstraZeneca's Imfinzi granted FDA priority review for less frequent dosing option for some cancersPharmaceutical company AstraZeneca's Imfinzi has received acceptance for its Biologics License Application and been granted Food and Drug Administration (FDA) priority review in the US for a new...
-
04 Aug
13:56Redx Pharma inks licencing pact with AstraZeneca for fibrosis treatmentDrug developer Redx Pharma said it had signed a significant out-licensing agreement for its fibrotic diseases treatment with AstraZeneca. AstraZeneca would take Redx Pharma's porcupine inhibitor,...
-
04 Aug
07:41AstraZeneca prices $3bn bond offeringPharmaceutical company AstraZeneca said it had priced a $3bn bond offering to fund general corporate purposes. The three-tranched offering, expected to close on 6 August, included $1.2bn of...
-
03 Aug
08:20Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLCCredit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 9000p). Story provided by StockMarketWire.com Broker...
-
31 Jul
12:10Broker Forecast - DZ Bank issues a broker note on AstraZeneca PLCDZ Bank today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7500p (from 7300p). Story provided by StockMarketWire.com Broker Forecasts data...
-
29 Jul
08:20Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLCBarclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9300p (from 9200p). Story provided by StockMarketWire.com Broker...
-
29 Jul
07:40AstraZeneca appoints Michel Demare as chairman of remuneration committeePharmaceutical company AstraZeneca said it had appointed Michel Demare as a member and chairman of the remuneration committee, with effect from 1 August 2020. Current remuneration committee...
-
28 Jul
10:42CORRECTION: AstraZeneca cancer treatments secure positive CHMP recommendations in EUPharmaceutical company AstraZeneca said its chronic leukaemia and lung cancer treatments had been recommended for marketing authorisation in the European Union. The positive recommendation for...
-
28 Jul
07:19AstraZeneca chronic kidney disease treatment meets primary goalBiopharmaceutical company AstraZeneca said its drug to treat patients with chronic kidney disease had met its primary and secondary goals. Results from AstraZeneca's Farxiga (dapagliflozin) phase...
-
24 Jul
07:19AstraZeneca lung disease treatment wins regulatory approval in USPharmaceutical company AstraZeneca said its drug to treat chronic obstructive pulmonary disease had been approved in the US. The approval of BreztriAerosphere by the US Food and Drug...
-
20 Jul
17:20FTSE ends lower as stimulus fears stifle vaccine news boostUK stocks ended Monday's trading session modestly lower as worries over the size of future financial packages in Europe and the US overshadowed positive Covid-19 vaccine and treatment data and oil...
-
20 Jul
14:58AstraZeneca says Covid-19 vaccine generates 'robust' immune responsePharmaceutical company AstraZeneca said a potential Covid-19 vaccine generated a 'robust' immune response against the SARS-CoV-2 virus in all participants, in a trial being led by Oxford...
-
09 Jul
17:04FTSE falls despite improved US jobs data, Rolls-Royce experiences turbulenceThe UK's flagship index ended in negative territory on Thursday as the global number of coronavirus cases topped 12 million and US markets followed Europe lower, despite gradual improvements to US...
-
09 Jul
12:04FTSE falls as virus worries weigh; Rolls-Royce experiences turbulenceThe UK's flagship index traded lower on Thursday as the global number of coronavirus cases topped 12 million and UK Chancellor Rishi Sunak warned of 'difficult times ahead' in a TV interview this...
-
09 Jul
09:14FTSE flails; Rolls-Royce experiences turbulenceThe UK's flagship index has headed lower on opening as the global number of coronavirus cases topped 12 million and UK Chancellor Rishi Sunak warned of 'difficult times ahead' in a TV interview...
-
09 Jul
07:10AstraZeneca stroke drug gets regulatory nod in USPharma giant AstraZeneca said the US Food and Drug Administration had accepted supplemental new drug application and granted priority review for a drug used to reduce subsequent stroke in patients...
-
08 Jul
07:20AstraZeneca pancreatic cancer treatment approved in EUPharma giant AstraZeneca said a pancreatic cancer treatment, jointly developed with Merck, had been approved in the European Union. The approval by the European Commission was based on results...
-
30 Jun
07:11AstraZeneca's neurofibromatosis drug granted orphan designation in JapanPharma giant AstraZeneca said its drug to treat neurofibromatosis type 1, a rare and debilitating genetic disease, had been granted orphan drug designation in Japan. Selumetinib, neurofibromatosis...
-
22 Jun
12:20Broker Forecast - Oddo issues a broker note on AstraZeneca PLCOddo today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to reduce (from buy) and cut its price target to 7600p (from 8100p). Story provided by StockMarketWire.com Broker...
-
15 Jun
12:12FTSE rebuilds after big losses at the open on second wave fearsThe FTSE 100 recovered some ground by lunchtime on Monday to trade back above the 6,000 mark, though there is still plenty of nervousness around about a second wave in the coronavirus pandemic...
-
15 Jun
09:17AstraZeneca to supply Oxford University's Covid-19 vaccine to EuropeDrugmaker AstraZeneca said it had reached an agreement with Europe's Inclusive Vaccines Alliance to supply up to 400m doses of the University of Oxford's COVID-19 vaccine. Deliveries of the...
-
08 Jun
16:57Mixed Monday for stocks as FTSE closes lowerThe FTSE 100 ended Monday in the red after a mixed day for the index saw optimism over an economic recovery offset by investors' profit taking and pharmaceutical giant AstraZeneca falling on merger...
-
08 Jun
12:33FTSE moves into positive territory on rising optimismThe FTSE 100 moved into positive territory by lunchtime on Monday as optimism over a recovery increased across various sectors, including airlines and housebuilders. The UK's benchmark index...